Back to Search
Start Over
Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.
- Source :
-
PloS one [PLoS One] 2013; Vol. 8 (2), pp. e57336. Date of Electronic Publication: 2013 Feb 20. - Publication Year :
- 2013
-
Abstract
- CD4(+) regulatory T cells (Tregs) are essential for the maintenance of the immune system's equilibrium, by dampening the activation of potential auto-reactive T cells and avoiding excessive immune activation. To correctly perform their function, Tregs must be maintained at the right proportion with respect to effector T cells. Since this equilibrium is frequently disrupted in individuals infected with the human immunodeficiency virus (HIV), we hypothesize that its deregulation could hamper immune reconstitution in patients with poor CD4(+) T cell recovery under highly active antiretroviral therapy (HAART). We analysed Tregs percentages amongst CD4(+) T cells in 53 HIV-infected patients under HAART, with suppression of viral replication and distinct levels of immune reconstitution. As controls, 51 healthy individuals were also analysed. We observed that amongst the patients with Nadir values (the lowest CD4(+) T cell counts achieved) <200 cells/µL, the individuals with high Tregs percentages (≥10% of total CD4(+) T cells) had the worse CD4(+) T cell reconstitution. In accordance, the well-described direct correlation between the Nadir value and CD4(+) T cell reconstitution is clearly more evident in individuals with high Tregs proportions. Furthermore, we observed a strong negative correlation between Tregs percentages and CD4(+) T cell recovery among immunological non-responder HIV(+) individuals. All together, this work shows that high Tregs frequency is an important factor associated with sub-optimal CD4(+) T cell recovery. This is particularly relevant for immunological non-responders with low Nadir values. Our results suggest that the Tregs proportion might be of clinical relevance to define cut-offs for HAART initiation.
- Subjects :
- Adult
Anti-HIV Agents pharmacology
Anti-HIV Agents therapeutic use
Antigens, CD genetics
Antigens, CD immunology
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Case-Control Studies
Female
HIV Infections drug therapy
HIV Infections pathology
HIV Infections virology
Humans
Immunologic Memory drug effects
Immunophenotyping
Lymphocyte Activation drug effects
Male
Middle Aged
T-Lymphocytes, Cytotoxic pathology
T-Lymphocytes, Cytotoxic virology
T-Lymphocytes, Regulatory pathology
T-Lymphocytes, Regulatory virology
Viral Load drug effects
HIV Infections immunology
HIV-1 immunology
T-Lymphocytes, Cytotoxic immunology
T-Lymphocytes, Regulatory immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 8
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 23437372
- Full Text :
- https://doi.org/10.1371/journal.pone.0057336